Nexo Therapeutics

About Nexo Therapeutics

Nexo Therapeutics is a biotechnology company focused on discovering and developing novel cancer therapies by pursuing drugs for some of cancer's most elusive targets. Their mission starts at the nexus of target biology and ligand discovery, using purpose-built platforms to address challenges in drug discovery.

Products & Services

INFINI-T:A biology engine powered by small molecule control of chimeric proteins to validate and guide target biology and pharmacology, aiding in the optimization of therapeutic leads.

CODON:A ligand discovery engine with a diverse library of over 10,000 covalent fragments for scalable biochemical and in-cell proteomics, targeting all ligandable amino acids to optimize hits into leads.

Specialties

Chemical Biology Covalent Ligand Discovery Cancer Therapies Target Biology Drug Discovery Platforms

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 60000000 MR: - FA: $60 million FAN: 60000000	D: 2023-07-26 FD: 2023-07-26	3 investors

Series A Latest

2023-07-26

$60.0M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Joe Patel

VP, Head of Discovery

R

Rhamy Zeid

VP, Head of Biology

J

John Athanasopoulos

VP, Head of Operations

M

Michael Kim

Chief Operating Officer

A

Andy Phillips

President, Chief Executive Officer

C

Carlo Rizzuto

Director

View 6 more team members with Pro

Unlock Full Team Directory

Recent News